PT Medifarma Laboratories

PT Medifarma Laboratories, established in 1970, is a prominent toll-manufacturing pharmaceutical company headquartered in Indonesia. With over five decades of operational experience, the company specializes in high-volume oral solid dosage forms, serving as a key partner for pharmaceutical product development and production. Its core offerings include comprehensive contract manufacturing and toll manufacturing services, alongside dedicated new product development support, all tailored to meet stringent client specifications and market demands. The company's strategic focus on quality and client satisfaction has positioned it as a reliable entity within the pharmaceutical sector.

Operating from a single primary location, PT Medifarma Laboratories manages a workforce of 500 - 1,000 employees. The company adheres to rigorous international quality standards, ensuring that its pharmaceutical products meet global benchmarks. This commitment enables Medifarma to export its high-quality oral solid dosage forms to various countries across Southeast Asia, demonstrating its broad market reach and operational capacity. The company's infrastructure supports large-scale production, making it a significant player in the regional pharmaceutical supply chain.

PT Medifarma Laboratories is dedicated to cultivating a supportive and inclusive work environment, fostering a culture that values its employees. This focus on human capital is integral to its operational success and long-term growth strategy. For insights into the people driving its innovation and production, one can explore Meet PT Medifarma Laboratories's team. The company generates substantial revenue, reported at $35.5M, underscoring its significant market presence and economic contribution within the healthcare and pharmaceutical industries.